Showing 141 - 160 results of 203 for search '"Cardiology"', query time: 0.07s Refine Results
  1. 141

    Nanomaterials: Promising Tools for the Diagnosis and Treatment of Myocardial Infarction by Ge Y, Wu L, Mei S, Wu J

    Published 2025-02-01
    “…Yanmin Ge, Lincong Wu, Shuyang Mei, Junduo Wu Department of Cardiology, The Second Hospital of Jilin University, Changchun, Jilin, 130000, People’s Republic of ChinaCorrespondence: Junduo Wu, Email [email protected]: Myocardial infarction (MI) is the leading cause of mortality from cardiovascular diseases. …”
    Get full text
    Article
  2. 142
  3. 143

    The Impact of diabetes on long-term prognosis in non-ST elevation acute coronary syndrome by Farouk BOUKERCHE, Leila HAMMOU, Nadia LAREDJ

    Published 2022-06-01
    “…Methods - A prospective study including all patients admitted to the cardiology department of CHU Oran for non-ST elevation ACS from November 2015 to October 2016 and with a five-year follow-up, a comparative study was carried out between the known diabetic group and the non-diabetic group in terms of occurrence of major adverse cardiovascular and cerebrovascular events. …”
    Get full text
    Article
  4. 144
  5. 145
  6. 146
  7. 147

    Infective Endocarditis - Diagnosis, Treatment and Specific Situations Management – Current Knowledge, Review of the Literature by Magdalena Balwierz, Agnieszka Kosińska, Wiktoria Belcarz

    Published 2025-02-01
    “…Material and methods             This article presents the current knowledge of the diagnosis and treatment in infective endocarditis, especially on the basis of the guidelines of European Society of Cardiology. Literature analysis, especially papers, which contain recent report in infective endocarditis treatment were analysed using the PubMed platform. …”
    Get full text
    Article
  8. 148
  9. 149
  10. 150

    Digital twins as global learning health and disease models for preventive and personalized medicine by Xinxiu Li, Joseph Loscalzo, A. K. M. Firoj Mahmud, Dina Mansour Aly, Andrey Rzhetsky, Marinka Zitnik, Mikael Benson

    Published 2025-02-01
    “…Early clinical applications of DTs have shown potential in areas like artificial organs, cancer, cardiology, and hospital workflow optimization. However, widespread implementation faces several challenges: (1) characterizing dynamic molecular changes across multiple biological scales; (2) developing computational methods to integrate data into DTs; (3) prioritizing disease mechanisms and therapeutic targets; (4) creating interoperable DT systems that can learn from each other; (5) designing user-friendly interfaces for patients and clinicians; (6) scaling DT technology globally for equitable healthcare access; (7) addressing ethical, regulatory, and financial considerations. …”
    Get full text
    Article
  11. 151
  12. 152
  13. 153

    Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis by Xue Han, Steven Fox, Michelle Chu, Jeff McCombs

    Published 2022-01-01
    “…**Objectives:** To estimate the effects of delaying treatment on the risk of cardiovascular-related hospitalization and on costs for patients who meet the criteria for secondary prevention as specified in the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines for Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. …”
    Get full text
    Article
  14. 154

    Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus by A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova, E. V. Bryukhovetskaya

    Published 2021-06-01
    “…The management of combined NAFLD-T2D requires a close inter-specialty involvement from hepatology, gastroenterology, endocrinology and cardiology. This interdisciplinary problem can be tackled through persuasive lifestyle recommendations and choosing rational medication strategies with a proved hepatoprotective efficacy.…”
    Get full text
    Article
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160

    Perceptions of Cardiovascular Healthcare Professionals Regarding Clinical Trials: A Survey-Based Study from the Middle East by Zainab Atiyah Dakhil, Hasan Ali Farhan, Mohammed Dheyaa Marsool, Mohammed Saad Qasim, Michele Peters, Jose Leal

    Published 2025-01-01
    “…Results: We surveyed n = 255 specialists (20% were women); interventional cardiologists constituted 44.7%, followed by cardiology trainees at 31%. Almost 30% reported having been involved in clinical trials, with data collection being the more frequently reported role (21.2%). …”
    Get full text
    Article